Schizophrenia Perspective

 
 
  • AACP 2021 Read clinically focused news coverage of key developments from Focus on Neuropsychiatry 2021
  • From Marathoner to Miler and Inpatient to Outpatient Psychiatry How I stumbled through my first month of outpatient medicine and how running helped me navigate these new challenges in the outpatient world.
  • Let's Talk About Race How psychiatrists can improve the understanding of the role race plays in psychiatric disorders.
  • ASCP 2021 Read clinically focused news coverage of key developments from ASCP 2021
  • SIRS 2021 Read clinically focused news coverage of key developments from SIRS 2021
  • The Impact of COVID-19 on Patients With Schizophrenia   Drs Frank Chen and Lorenzo Norris discuss the impact the COVID-19 pandemic has had on patients with schizophrenia.
  • The Outrageous Costs of Treating Functional Disorders of the Brain A neurologist outlines the pitfalls of managing functional disorders of the brain in the emergency room.
  • Vaccine Trials Prove Clinical Trial Diversity Is Doable The COVID vaccine trials had good representation of minority patients, but they're the exception, not the rule. John Whyte, MD, challenges investigators across medicine to do better.
  • Believing in Conspiracy Theories Is Not Delusional Two psychiatrists offer advice on distinguishing between belief in conspiracies and outright delusions.
  • Cannabis and Cannabinoids: Weighing the Benefits and Risks in Psychiatric Patients   Dr Diana Martinez of Columbia University discusses the interaction between cannabis and psychiatric disorders.
  • Systemic Racism in Psychiatry Is Real   Drs Steve Strakowski, Roberto Luis-Fernandez, and Harold Neighbors on the uncomfortable but essential questions that psychiatry must ask itself if it is going to ensure equal care for all.
  • Is Ketamine Living Up to the Promise for Depression?   Columbia psychiatrist Lloyd Sederer talks with his colleague J. John Mann, a leading ketamine researcher and clinician, about the promise surrounding this treatment and the questions that remain.
  • Schizophrenia: Overview Video   Schizophrenia is a type of mental disorder characterized by certain symptoms, including delusions, hallucinations, alogia, and cognitive issues. Review key aspects in this short video.
  • APA Tackles Structural Racism in Psychiatry, Itself A new APA task force aims to address structural and institutional racism in psychiatry.
  • COVID-19, Police Reform, and Fixing a Broken Mental Health System   Lloyd Sederer talks with political scientist Norm Ornstein about how politics has degraded our response to COVID-19 and serious mental illness, as well as a proven approach to police reform.
  • COVID-19 in People With Schizophrenia Jeffrey Lieberman, MD, director of the New York State Psychiatric Institute and psychiatrist-in-chief at the Columbia University Medical Center of NewYork-Presbyterian Hospital, helps us understand how COVID-19 affects patients with schizophrenia and other psychotic illnesses.
  • The Future of Psychiatric Diagnosis   Melissa Arbuckle talks with Jeffrey Lieberman about the search for diagnostic tests for psychiatric diagnoses, and why he is optimistic about the strides we've made and those to come.
  • ASCP 2020 Read clinically focused news coverage of key developments from ASCP 2020
  • Researching Psychedelics for Psychiatric Disorders MDEdge spoke with psychedelic researcher Dr Frederick Barrett about the future of psychedelic compounds in psychiatric care.
  • SIRS 2020 Read clinically focused news coverage of key developments from SIRS 2020